|
|
Blood, 1 October 2005, Vol. 106, No. 7, pp. 2452-2461.
Prepublished online as a Blood First Edition Paper on June 21, 2005; DOI 10.1182/blood-2005-02-0734.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations
Hui Luo,
Qing Li,
Julie O'Neal,
Friederike Kreisel,
Michelle M. Le Beau, and
Michael H. Tomasson
From the Department of Medicine and Genetics, Division of Oncology, and the Department of Pathology, Washington University School of Medicine, St Louis, MO; and the Department of Hematology/Oncology, University of Chicago, IL.
Ectopic expression of c-Myc (Myc) in most primary cell types results in programmed cell death, and malignant transformation cannot occur without additional mutations that block apoptosis. The development of Myc-induced lymphoid tumors has been well studied and supports this model. Myc can be upregulated in acute myeloid leukemia (AML), but its exact role in myeloid leukemogenesis is unclear. To study its role in AML, we used a murine stem cell virus (MSCV) retroviral gene transfer/transplantation system to broadly express Myc in the bone marrow of mice either alone or in combination with antiapoptotic mutations. Myc expression in the context either of Arf/Ink4a loss or Bcl-2 coexpression induced a mixture of acute myeloid and acute lymphoid leukemias (AML+ALL). In the absence of antiapoptotic mutations however, all mice transplanted with MSCV-Myc (100%, n = 110) developed AML exclusively. MSCV-Myc-induced AML was polyclonal, readily transplantable, possessed an intact Arf-p53 pathway, and did not display cytogenetic abnormalities by spectral karyotyping (SKY) analysis. Lastly, we found that Myc preferentially stimulated the growth of myeloid progenitor cells in methylcellulose. These data provide the first direct evidence that Myc is a critical downstream effector of myeloid leukemogenesis and suggest that myeloid progenitors are intrinsically resistant to Myc-induced apoptosis. (Blood. 2005;106: 2452-2461)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. Bonetti, T. Davoli, C. Sironi, B. Amati, P. G. Pelicci, and E. Colombo
Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7{gamma}
J. Cell Biol.,
July 14, 2008;
182(1):
19 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kawagoe, A. Kandilci, T. A. Kranenburg, and G. C. Grosveld
Overexpression of N-Myc Rapidly Causes Acute Myeloid Leukemia in Mice
Cancer Res.,
November 15, 2007;
67(22):
10677 - 10685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Parikh, R. Subrahmanyam, and R. Ren
Oncogenic NRAS, KRAS, and HRAS Exhibit Different Leukemogenic Potentials in Mice
Cancer Res.,
August 1, 2007;
67(15):
7139 - 7146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Boyapati, M. Yan, L. F. Peterson, J. R. Biggs, M. M. Le Beau, and D.-E. Zhang
A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy
Blood,
May 1, 2007;
109(9):
3963 - 3971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Cain, Z. Xiang, J. O'Neal, F. Kreisel, A. Colson, H. Luo, L. Hennighausen, and M. H. Tomasson
Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage
Blood,
May 1, 2007;
109(9):
3906 - 3914.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Xiang, F. Kreisel, J. Cain, A. Colson, and M. H. Tomasson
Neoplasia Driven by Mutant c-KIT Is Mediated by Intracellular, Not Plasma Membrane, Receptor Signaling
Mol. Cell. Biol.,
January 1, 2007;
27(1):
267 - 282.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
